NSAIDs in COVID-19, friend or foe?

IF 0.2 Q4 ANESTHESIOLOGY

Anaesthesia, Pain & Intensive Care Pub Date : 2023-01-31 DOI:10.35975/apic.v27i1.2123

Reham Mahrous, Amr Abdelnasser, Raghda Fouda, Mohamed Abd Al Moniem Morsy, Omnia Mandour

引用次数: 0

Abstract

At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be associated with increased risk of complications of lower respiratory tract infections. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients. Key words: COVID-19; pandemic; NSAIDs Citation: Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. NSAIDs in COVID-19, friend or foe? Anaesth. pain intensive care 2022;27(1):119−122; DOI: 10.35975/apic.v27i1.2123 Received: May 29, 2022; Reviewed: June 28, 2022; Accepted: July 03, 2022

查看原文本刊更多论文

非甾体抗炎药对COVID-19是敌是友?

在COVID-19大流行开始时，避免使用非甾体抗炎药。这是因为先前的研究表明，非甾体抗炎药可能与下呼吸道感染并发症的风险增加有关。后来的研究涉及使用非甾体抗炎药治疗某些慢性疾病的患者，并没有显示这些患者有额外的危害。随后，许多研究评估了在COVID-19患者中使用非甾体抗炎药治疗疼痛和发烧的益处，并显示这些患者没有额外的风险。关键词:COVID-19;大流行;非甾体抗炎药# x0D;引用本文:Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. nsaid在COVID-19中的作用:是敌是友?Anaesth。疼痛重症监护2022;27(1):119−122;DOI: 10.35975 / apic.v27i1.2123& # x0D;收稿日期:2022年5月29日;审核时间:2022年6月28日;录用日期:2022年7月3日

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊